BioSpace News Archive

ZIVO anticipates that it will enter into a definitive, binding production agreement with Norland later in 2018.

Flemming Ornskov, MD, M.P.H., Chief Executive Officer and John Miller, Interim Chief Financial Officer will host the investor and analyst conference call at 9:00 am EST / 14:00 GMT.

InSure FIT more sensitive than OC FIT-CHEK and Hemoccult II SENSA for detecting advanced colorectal neoplasia.

ClearFlow announced that the cover of the January 2018 issue of The Annals of Thoracic Surgery features a review article that elucidates the biological mechanisms by which retained shed mediastinal blood can trigger postoperative atrial fibrillation (POAF) in susceptible individuals as well as how this could represent a new target for prevention of POAF.

Dr. Ernest Loumaye extends his gratitude to Dr Frank Verwiel and the Office of the CEO for overseeing the operations of the Company during his absence.

Financial and operating highlights during the third quarter of fiscal 2018 include:

Viking today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Aethlon Medical today announced results for its fiscal third quarter ended December 31, 2017.

Edwards Lifesciences, today reported financial results for the quarter ended December 31, 2017.

Ironwood today announced it will host its fourth quarter and full-year 2017 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, February 15, 2018.